Standout Papers

Enhanced preclinical antitumor activity of M7824, a bifunctional fusion protein simultaneously targeting... 2018 2026 2020 2023 401
  1. Enhanced preclinical antitumor activity of M7824, a bifunctional fusion protein simultaneously targeting PD-L1 and TGF-β (2018)
    Yan Lan, Dong Zhang et al. Science Translational Medicine

Immediate Impact

2 by Nobel laureates 6 from Science/Nature 57 standout
Sub-graph 1 of 22

Citing Papers

Pyridinium Rotor Strategy toward a Robust Photothermal Agent for STING Activation and Multimodal Image-Guided Immunotherapy for Triple-Negative Breast Cancer
2025 Standout
The present and future of bispecific antibodies for cancer therapy
2024 Standout
1 intermediate paper

Works of George Locke being referenced

Enhanced preclinical antitumor activity of M7824, a bifunctional fusion protein simultaneously targeting PD-L1 and TGF-β
2018 Standout

Author Peers

Author Last Decade Papers Cites
George Locke 236 335 68 186 9 532
Anja Wimmel 403 253 42 221 11 592
Karthik Dhatchinamoorthy 263 318 63 324 7 612
Natalie McGregor 220 236 82 140 8 494
Sangeeta Kakoti 239 481 115 252 12 619
Endang Nuryadi 236 448 119 219 11 612
Torill Høiby 311 253 35 268 8 648
Vid Leko 224 273 33 238 11 594
Katharina M. Brauer 215 214 64 230 10 541
Haichun Huang 139 414 100 238 11 606
Zenobia D’Costa 265 396 81 170 14 641

All Works

Loading papers...

Rankless by CCL
2026